Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

Celgene Corporation (CELG)

-NasdaqGS
87.16 0.97(1.13%) Jul 25, 4:00PM EDT
Prev Close:86.19
Open:86.26
Bid:86.01 x 100
Ask:87.51 x 100
1y Target Est:99.46
Beta:1.11
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:85.88 - 87.46
52wk Range:65.76 - 90.50
Volume:3,544,882
Avg Vol (3m):5,005,960
Market Cap:69.80B
P/E (ttm):27.74
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 1.13%69.80B
JNJ288.88B

Key Statistics

Forward P/E (1 yr):17.82
P/S (ttm):9.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback